Reduction of c-Fos via Overexpression of miR-34a Results in Enhancement of TNF- Production by LPS in Neutrophils from Myelodysplastic Syndrome Patients

• Yayoi Shikama ,

  * E-mail: yayois@fmu.ac.jp

  Current address: Center for Medical Education and Career Development, Fukushima Medical University, Fukushima, Japan

  Affiliation Department of Pharmacology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Meiwan Cao,

  Affiliation Department of Pharmacology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Tomoyuki Ono,

  Affiliation Department of Pharmacology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Xiaomin Feng,

  Current address: International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan

  Affiliation Department of Pharmacology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Hideyoshi Noji,

  Affiliation Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Hideo Kimura,

  Affiliation Department of Hematology, Kita Fukushima Medical Center, Date, Japan

  ⨯
• Kazuei Ogawa,

  Affiliation Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Yuko Suzuki,

  Affiliation Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Kazuhiko Ikeda,

  Affiliations Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan, Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Yasuchika Takeishi,

  Affiliation Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan

  ⨯
• Junko Kimura

  Affiliation Department of Pharmacology, Fukushima Medical University, Fukushima, Japan

  ⨯